Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prevention of Depression in Patients Being Treated for Head and Neck Cancer.

Trial Profile

Prevention of Depression in Patients Being Treated for Head and Neck Cancer.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Feb 2018

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Depressive disorders
  • Focus Therapeutic Use
  • Acronyms PROTECT
  • Most Recent Events

    • 22 May 2013 Results presented at the 166th Annual Meeting of the American Psychiatric Association.
    • 22 Mar 2013 Primary endpoint 'Quick-Inventory-of-Depressive-Symptomology-Self-Report' has been met according to results presented at the 166th Annual Meeting of the American Psychiatric Association.
    • 08 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top